Pillar Pacific Capital Management’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-10,000
| Closed | -$48K | – | 301 |
|
|
2020
Q2 | $48K | Hold |
10,000
| – | – | 0.01% | 290 |
|
|
2020
Q1 | $20K | Hold |
10,000
| – | – | ﹤0.01% | 270 |
|
|
2019
Q4 | $35K | Hold |
10,000
| – | – | ﹤0.01% | 292 |
|
|
2019
Q3 | $29K | Hold |
10,000
| – | – | ﹤0.01% | 286 |
|
|
2019
Q2 | $38K | Hold |
10,000
| – | – | ﹤0.01% | 296 |
|
|
2019
Q1 | $81K | Hold |
10,000
| – | – | 0.01% | 291 |
|
|
2018
Q4 | $81K | Sell |
10,000
-800
| -7% | -$6.48K | 0.01% | 277 |
|
|
2018
Q3 | $82K | Hold |
10,800
| – | – | 0.01% | 304 |
|
|
2018
Q2 | $62K | Hold |
10,800
| – | – | 0.01% | 300 |
|
|
2018
Q1 | $52K | Sell |
10,800
-850
| -7% | -$4.09K | 0.01% | 290 |
|
|
2017
Q4 | $57K | Sell |
11,650
-350
| -3% | -$1.71K | 0.01% | 291 |
|
|
2017
Q3 | $62K | Hold |
12,000
| – | – | 0.01% | 292 |
|
|
2017
Q2 | $67K | Hold |
12,000
| – | – | 0.01% | 296 |
|
|
2017
Q1 | $101K | Sell |
12,000
-7,000
| -37% | -$58.9K | 0.01% | 295 |
|
|
2016
Q4 | $120K | Hold |
19,000
| – | – | 0.02% | 296 |
|
|
2016
Q3 | $84K | Hold |
19,000
| – | – | 0.01% | 298 |
|
|
2016
Q2 | $54K | Hold |
19,000
| – | – | 0.01% | 297 |
|
|
2016
Q1 | $53K | Hold |
19,000
| – | – | 0.01% | 293 |
|
|
2015
Q4 | $196K | Hold |
19,000
| – | – | 0.04% | 274 |
|
|
2015
Q3 | $217K | Hold |
19,000
| – | – | 0.04% | 256 |
|
|
2015
Q2 | $283K | Buy |
+19,000
| New | +$283K | 0.05% | 223 |
|